Influence of GnRH analog therapy on body mass in central precocious puberty

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 15, Issue 1, 2009, Pages 7-11

  Gła̧b, Ewa ^a   Barg, Ewa ^a   Wikiera, Beata ^a   Grabowski, Marcin ^b   Noczyńska, Anna ^a  

^a Klinika Endokrynologii i Diabetologii Wieku Rozwojowego   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Body mass index (BMI); GnRH analog therapy; Obesity; Overweight; Precocious puberty

Indexed keywords

TRIPTORELIN;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OBESITY; ONSET AGE; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; SCHOOL CHILD; COHORT ANALYSIS; COMORBIDITY; DRUG EFFECT; PREVALENCE;

BODY HEIGHT; BODY MASS INDEX; CHILD; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; OBESITY; OVERWEIGHT; PREVALENCE; PUBERTY, PRECOCIOUS; TRIPTORELIN;

EID: 84873235537     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Heger S., Partsch C.J., Sippell W.G.: Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J. Clin. Endocrinol. Metab., 1999, 84, 4583-4590.
2. Paterson W.F., McNeill E., Young D., Donaldson M.D.: Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Clin. Endocrinol., 2004, 61, 626-634.
3. Lazar L., Padoa A., Phillip M.: Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity. J. Clin. Endocrinol. Metab., 2007, 92, 3483-3489.
4. Chemaitilly W., Trivin C., Adan L., Gall V., Sainte-Rose C., Brauner R.: Central precocious puberty: clinical and laboratory features. Clin. Endocrinol., 2001, 54, 289-294.
5. Arrigo T., De Luca F., Antoniazzi F., Galluzzi F., Segni M., Rosano M., Messina M.F., Lombardo F.: Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. Eur. J. Endocrinol., 2004, 150, 533-537.
6. Palmert M.R., Mansfield M.J., Crowley W.F. Jr., Crigler J.F. Jr., Crawford J.D., Boepple P.A.: Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J. Clin. Endocrinol. Metab., 1999, 84, 480-4488.
7. Biro F.M., Khoury P., Morrison J.A.: Influence of obesity on timing of puberty. Int. J. Androl., 2006, 29, 272-277.
8. Davison K.K., Susman E.J., Birch L.L.: Percent body fat at age 5 predicts earlier pubertal development among girls at age 9. Pediatrics, 2003, 111, 815-821.
9. Frisch R.E., Mc Arthur J.W.: Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance and onset. Science, 1974, 185, 949-951.
10. Frisch R.E.: Body fat, menarche, fitness and fertility. Hum. Reprod., 1987, 2, 521-533.
11. Scott E.C., Johnston F.E.: Critical fat, menarche, and the maintenance of menstrual cycles: a critical review. J. Adolesc. Health Care. 1982, 2, 249-260.
12. De Ridder C.M., Thijssen J.H., Bruning P.F., Van den Brande J.L., Zonderland M.L., Erich W.B.: Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls. J. Clin. Endocrinol. Metab., 1992, 75, 442-446.
13. Kaplowitz P.B., Slora E.J., Wasserman R.C., Pedlow S.E., Herman-Giddens M.E.: Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics, 2001, 108, 347-353.
14. Lee J.M., Appugliese D., Kaciroti N., Corwyn R.F., Bradley R.H., Lumeng J.C.: Weight status in young girls and the onset of puberty. Pediatrics, 2007, 119, e624-630.
15. Pescovitz O.H., Hench K.D., Barnes K.M., Loriaux D.L., Cutler G.B. Jr.: Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J. Clin. Endocrinol. Metab., 1988, 67, 474-479.
16. Rolland-Cachera M.F.: Body composition during adolescence: methods, limitations and determinants. Hormone Research, 1993, 39, 25-40.
17. Greulich W.W., Pyle S.I.: Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press. 1959.
18. Marshall W.A., Tanner J.M.: Variations in the pattern of pubertal changes in girls. Arch. Dis. Child., 1969, 44, 291-303.
19. Matusik P., Malecka-Tendera E., Klimek K.: Polish Childhood Obesity Study Group: Nutritional state of Polish prepubertal children assessed by population-specific and international standards. Acta Paediatr., 2007, 96, 276-280.
20. Sørensen K., Andersson A.M., Skakkebaek N.E., Juul A.: Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment. J. Clin. Endocrinol. Metab., 2007, 92, 3189-3196.
21. Ball G.D., Huang T.T., Gower B.A., Cruz M.L., Shaibi G.Q., Weigensberg M.J., Goran M.I.: Longitudinal changes in insulin sensitivity, insulin secretion, and β-cell function during puberty. J. Pediatr., 2006, 148, 16-22.
22. Galloway P.J., Donaldson M.D., Wallace A.M.: Sex hormone binding globulin concentration as a prepubertal marker for hyperinsulinaemia in obesity. Arch. Dis. Child., 2001, 85, 489-491.
23. Klein K.O., Larmore K.A., de Lancey E., Brown J.M., Considine R.V., Hassink S.G.: Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J. Clin. Endocrinol. Metab., 1998, 83, 3469-3475.
24. Russell D.L., Keil M.F., Bonat S.H., Uwaifo G.I., Nicholson J.C., McDuffie J.R., Hill S.C., Yanovski J.A.: The relation between skeletal maturation and adiposity in African American and Caucasian children. J. Pediatr., 2001, 139, 844-848.
25. Garcia-Mayor R.V., Andrade M.A., Rios M., Lage S., Dieguez C., Casanueva F.F.: Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage. J. Clin. Endocrinol. Metab., 1997, 82, 2849-2855.
26. Blum W.F., Englaro P., Hanitsch S., Juul A., Hertel N.T., Müller J., Skakkebaek N.E., Heiman M.L., Birkett M., Attanasio A.M., Kiess W., Rascher A.: Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J. Clin. Endocrinol. Metab., 1997, 82, 2904-2910.
27. Lazar L., Kauli R., Pertzelan A., Phillip M.: Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J. Clin. Endocrinol. Metab., 2002, 87, 2090-2094.
28. Van der Sluis I.M., Boot A.M., Krenning E.P., Drop S.L., de Muinck Keizer-Schrama S.M.: Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J. Clin. Endocrinol. Metab., 2002, 87, 506-512.